317 related articles for article (PubMed ID: 32360494)
1. Attention-Deficit/Hyperactivity Disorder in 2- to 5-Year-Olds: A Primary Care Network Experience.
Bannett Y; Feldman HM; Gardner RM; Blaha O; Huffman LC
Acad Pediatr; 2021 Mar; 21(2):280-287. PubMed ID: 32360494
[TBL] [Abstract][Full Text] [Related]
2. Variation in Rate of Attention-Deficit/Hyperactivity Disorder Management by Primary Care Providers.
Bannett Y; Feldman HM; Bentley JP; Ansel DA; Wang CJ; Huffman LC
Acad Pediatr; 2020 Apr; 20(3):384-390. PubMed ID: 31794864
[TBL] [Abstract][Full Text] [Related]
3. Factors Associated with Attention Deficit Hyperactivity Disorder Medication Use in Community Care Settings.
Kamimura-Nishimura KI; Epstein JN; Froehlich TE; Peugh J; Brinkman WB; Baum R; Gardner W; Langberg JM; Lichtenstein P; Chen D; Kelleher KJ
J Pediatr; 2019 Oct; 213():155-162.e1. PubMed ID: 31300310
[TBL] [Abstract][Full Text] [Related]
4. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
Foy JM; Earls MF
Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
[TBL] [Abstract][Full Text] [Related]
5. Primary Care Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in School-Age Children: Trends and Disparities During the COVID-19 Pandemic.
Bannett Y; Dahlen A; Huffman LC; Feldman HM
J Dev Behav Pediatr; 2022 Sep; 43(7):386-392. PubMed ID: 35503665
[TBL] [Abstract][Full Text] [Related]
6. Pharmacotherapy for incident attention-deficit/hyperactivity disorder: practice patterns and quality metrics.
Bussing R; Narwaney KJ; Winterstein AG; Newton DA; DeBar L; Boscarino JA; Toh S; Pawloski P; Nordin JD; Herrinton LJ; Mason D; Daley MF
Curr Med Res Opin; 2014 Aug; 30(8):1687-99. PubMed ID: 24635013
[TBL] [Abstract][Full Text] [Related]
7. Antipsychotic Treatment Among Youths With Attention-Deficit/Hyperactivity Disorder.
Sultan RS; Wang S; Crystal S; Olfson M
JAMA Netw Open; 2019 Jul; 2(7):e197850. PubMed ID: 31348506
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of Treatment for Preschoolers on Kentucky Medicaid Diagnosed with Attention-Deficit/Hyperactivity Disorder.
Davis DW; Feygin Y; Creel L; Kong M; Jawad K; Sun J; Blum NJ; Lohr WD; Williams PG; Le J; Jones VF; Pasquenza N
J Child Adolesc Psychopharmacol; 2020 Sep; 30(7):448-455. PubMed ID: 32614247
[No Abstract] [Full Text] [Related]
9. Psychotropic medication use in a population of children who have attention-deficit/hyperactivity disorder.
Guevara J; Lozano P; Wickizer T; Mell L; Gephart H
Pediatrics; 2002 May; 109(5):733-9. PubMed ID: 11986429
[TBL] [Abstract][Full Text] [Related]
10. Physician Office Visits for Attention-deficit/Hyperactivity Disorder in Children and Adolescents Aged 4-17 Years: United States, 2012-2013.
Albert M; Rui P; Ashman JJ
NCHS Data Brief; 2017 Jan; (269):1-8. PubMed ID: 28135186
[TBL] [Abstract][Full Text] [Related]
11. ADHD Treatment in Primary Care: Demographic Factors, Medication Trends, and Treatment Predictors.
Hauck TS; Lau C; Wing LLF; Kurdyak P; Tu K
Can J Psychiatry; 2017 Jun; 62(6):393-402. PubMed ID: 28103079
[TBL] [Abstract][Full Text] [Related]
12. Preschool ADHD Diagnosis and Stimulant Use Before and After the 2011 AAP Practice Guideline.
Fiks AG; Ross ME; Mayne SL; Song L; Liu W; Steffes J; McCarn B; Grundmeier RW; Localio AR; Wasserman R
Pediatrics; 2016 Dec; 138(6):. PubMed ID: 27940706
[TBL] [Abstract][Full Text] [Related]
13. Common Use of Stimulants and Alpha-2 Agonists to Treat Preschool Attention-Deficit Hyperactivity Disorder: A DBPNet Study.
Blum NJ; Shults J; Harstad E; Wiley S; Augustyn M; Meinzen-Derr JK; Wolraich ML; Barbaresi WJ
J Dev Behav Pediatr; 2018 Sep; 39(7):531-537. PubMed ID: 29851669
[TBL] [Abstract][Full Text] [Related]
14. Use of practice guidelines in the primary care of children with attention-deficit/hyperactivity disorder.
Rushton JL; Fant KE; Clark SJ
Pediatrics; 2004 Jul; 114(1):e23-8. PubMed ID: 15231969
[TBL] [Abstract][Full Text] [Related]
15. Young Children with Attention-Deficit/Hyperactivity Disorder and/or Disruptive Behavior Disorders Are More Frequently Prescribed Alpha Agonists Than Stimulants.
Mittal S; Boan AD; Kral MC; Lally MD; van Bakergem K; Macias MM; LaRosa A
J Child Adolesc Psychopharmacol; 2020 Mar; 30(2):81-86. PubMed ID: 31621385
[No Abstract] [Full Text] [Related]
16. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.
Goldman LS; Genel M; Bezman RJ; Slanetz PJ
JAMA; 1998 Apr; 279(14):1100-7. PubMed ID: 9546570
[TBL] [Abstract][Full Text] [Related]
17. Genetic, Clinical, and Sociodemographic Factors Associated With Stimulant Treatment Outcomes in ADHD.
Brikell I; Wimberley T; Albiñana C; Pedersen EM; Vilhjálmsson BJ; Agerbo E; Demontis D; Børglum AD; Schork AJ; LaBianca S; Werge T; Mors O; Hougaard DM; Thapar A; Mortensen PB; Dalsgaard S
Am J Psychiatry; 2021 Sep; 178(9):854-864. PubMed ID: 34154395
[TBL] [Abstract][Full Text] [Related]
18. Factors Associated With Children Diagnosed With Attention-Deficit/Hyperactivity Disorder and 30-Day Follow-up Care With Practitioners Among Medicaid Recipients in Georgia.
Yin H; Ibe B; Parr TL; Csukas S; Jones BL; Thompson S
Qual Manag Health Care; 2022 Jul-Sep 01; 31(3):154-159. PubMed ID: 34571512
[TBL] [Abstract][Full Text] [Related]
19. Is attention deficit hyperactivity disorder increasing among girls in the US? Trends in diagnosis and the prescribing of stimulants.
Robison LM; Skaer TL; Sclar DA; Galin RS
CNS Drugs; 2002; 16(2):129-37. PubMed ID: 11825103
[TBL] [Abstract][Full Text] [Related]
20. Care Provision and Prescribing Practices of Physicians Treating Children and Adolescents With ADHD.
Patel A; Medhekar R; Ochoa-Perez M; Aparasu RR; Chan W; Sherer JT; Alonzo J; Chen H
Psychiatr Serv; 2017 Jul; 68(7):681-688. PubMed ID: 28196459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
